Global Parkinsons Disease Drug Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Global Parkinsons Disease Drug Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Table of Contents

1 Market Overview
1.1 Parkinsons Disease Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Parkinsons Disease Drug Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Carbidopa/Levodopa
1.2.3 Dopamine Receptor Agonists
1.2.4 MAO-Inhibitors
1.3 Market Analysis by Application
1.3.1 Overview: Global Parkinsons Disease Drug Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Other
1.4 Global Parkinsons Disease Drug Market Size & Forecast
1.4.1 Global Parkinsons Disease Drug Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Parkinsons Disease Drug Sales in Volume (2017-2028)
1.4.3 Global Parkinsons Disease Drug Price (2017-2028)
1.5 Global Parkinsons Disease Drug Production Capacity Analysis
1.5.1 Global Parkinsons Disease Drug Total Production Capacity (2017-2028)
1.5.2 Global Parkinsons Disease Drug Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Parkinsons Disease Drug Market Drivers
1.6.2 Parkinsons Disease Drug Market Restraints
1.6.3 Parkinsons Disease Drug Trends Analysis
2 Manufacturers Profiles
2.1 Teva
2.1.1 Teva Details
2.1.2 Teva Major Business
2.1.3 Teva Parkinsons Disease Drug Product and Services
2.1.4 Teva Parkinsons Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Novartis AG
2.2.1 Novartis AG Details
2.2.2 Novartis AG Major Business
2.2.3 Novartis AG Parkinsons Disease Drug Product and Services
2.2.4 Novartis AG Parkinsons Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 GSK
2.3.1 GSK Details
2.3.2 GSK Major Business
2.3.3 GSK Parkinsons Disease Drug Product and Services
2.3.4 GSK Parkinsons Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 AbbVie
2.4.1 AbbVie Details
2.4.2 AbbVie Major Business
2.4.3 AbbVie Parkinsons Disease Drug Product and Services
2.4.4 AbbVie Parkinsons Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Merck
2.5.1 Merck Details
2.5.2 Merck Major Business
2.5.3 Merck Parkinsons Disease Drug Product and Services
2.5.4 Merck Parkinsons Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Boehringer Ingelheim
2.6.1 Boehringer Ingelheim Details
2.6.2 Boehringer Ingelheim Major Business
2.6.3 Boehringer Ingelheim Parkinsons Disease Drug Product and Services
2.6.4 Boehringer Ingelheim Parkinsons Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Impax Laboratories
2.7.1 Impax Laboratories Details
2.7.2 Impax Laboratories Major Business
2.7.3 Impax Laboratories Parkinsons Disease Drug Product and Services
2.7.4 Impax Laboratories Parkinsons Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Lundbeck
2.8.1 Lundbeck Details
2.8.2 Lundbeck Major Business
2.8.3 Lundbeck Parkinsons Disease Drug Product and Services
2.8.4 Lundbeck Parkinsons Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Sun Pharma
2.9.1 Sun Pharma Details
2.9.2 Sun Pharma Major Business
2.9.3 Sun Pharma Parkinsons Disease Drug Product and Services
2.9.4 Sun Pharma Parkinsons Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Wockhardt
2.10.1 Wockhardt Details
2.10.2 Wockhardt Major Business
2.10.3 Wockhardt Parkinsons Disease Drug Product and Services
2.10.4 Wockhardt Parkinsons Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 UCB
2.11.1 UCB Details
2.11.2 UCB Major Business
2.11.3 UCB Parkinsons Disease Drug Product and Services
2.11.4 UCB Parkinsons Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Bausch Health
2.12.1 Bausch Health Details
2.12.2 Bausch Health Major Business
2.12.3 Bausch Health Parkinsons Disease Drug Product and Services
2.12.4 Bausch Health Parkinsons Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Acadia
2.13.1 Acadia Details
2.13.2 Acadia Major Business
2.13.3 Acadia Parkinsons Disease Drug Product and Services
2.13.4 Acadia Parkinsons Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Parkinsons Disease Drug Breakdown Data by Manufacturer
3.1 Global Parkinsons Disease Drug Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Parkinsons Disease Drug Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Parkinsons Disease Drug
3.4 Market Concentration Rate
3.4.1 Top 3 Parkinsons Disease Drug Manufacturer Market Share in 2021
3.4.2 Top 6 Parkinsons Disease Drug Manufacturer Market Share in 2021
3.5 Global Parkinsons Disease Drug Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Parkinsons Disease Drug Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Parkinsons Disease Drug Market Size by Region
4.1.1 Global Parkinsons Disease Drug Sales in Volume by Region (2017-2028)
4.1.2 Global Parkinsons Disease Drug Revenue by Region (2017-2028)
4.2 North America Parkinsons Disease Drug Revenue (2017-2028)
4.3 Europe Parkinsons Disease Drug Revenue (2017-2028)
4.4 Asia-Pacific Parkinsons Disease Drug Revenue (2017-2028)
4.5 South America Parkinsons Disease Drug Revenue (2017-2028)
4.6 Middle East and Africa Parkinsons Disease Drug Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Parkinsons Disease Drug Sales in Volume by Type (2017-2028)
5.2 Global Parkinsons Disease Drug Revenue by Type (2017-2028)
5.3 Global Parkinsons Disease Drug Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Parkinsons Disease Drug Sales in Volume by Application (2017-2028)
6.2 Global Parkinsons Disease Drug Revenue by Application (2017-2028)
6.3 Global Parkinsons Disease Drug Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Parkinsons Disease Drug Sales by Type (2017-2028)
7.2 North America Parkinsons Disease Drug Sales by Application (2017-2028)
7.3 North America Parkinsons Disease Drug Market Size by Country
7.3.1 North America Parkinsons Disease Drug Sales in Volume by Country (2017-2028)
7.3.2 North America Parkinsons Disease Drug Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Parkinsons Disease Drug Sales by Type (2017-2028)
8.2 Europe Parkinsons Disease Drug Sales by Application (2017-2028)
8.3 Europe Parkinsons Disease Drug Market Size by Country
8.3.1 Europe Parkinsons Disease Drug Sales in Volume by Country (2017-2028)
8.3.2 Europe Parkinsons Disease Drug Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Parkinsons Disease Drug Sales by Type (2017-2028)
9.2 Asia-Pacific Parkinsons Disease Drug Sales by Application (2017-2028)
9.3 Asia-Pacific Parkinsons Disease Drug Market Size by Region
9.3.1 Asia-Pacific Parkinsons Disease Drug Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Parkinsons Disease Drug Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Parkinsons Disease Drug Sales by Type (2017-2028)
10.2 South America Parkinsons Disease Drug Sales by Application (2017-2028)
10.3 South America Parkinsons Disease Drug Market Size by Country
10.3.1 South America Parkinsons Disease Drug Sales in Volume by Country (2017-2028)
10.3.2 South America Parkinsons Disease Drug Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Parkinsons Disease Drug Sales by Type (2017-2028)
11.2 Middle East & Africa Parkinsons Disease Drug Sales by Application (2017-2028)
11.3 Middle East & Africa Parkinsons Disease Drug Market Size by Country
11.3.1 Middle East & Africa Parkinsons Disease Drug Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Parkinsons Disease Drug Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Parkinsons Disease Drug and Key Manufacturers
12.2 Manufacturing Costs Percentage of Parkinsons Disease Drug
12.3 Parkinsons Disease Drug Production Process
12.4 Parkinsons Disease Drug Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Parkinsons Disease Drug Typical Distributors
13.3 Parkinsons Disease Drug Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Parkinsons Disease Drug Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Parkinsons Disease Drug Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Teva Basic Information, Manufacturing Base and Competitors
Table 4. Teva Major Business
Table 5. Teva Parkinsons Disease Drug Product and Services
Table 6. Teva Parkinsons Disease Drug Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 8. Novartis AG Major Business
Table 9. Novartis AG Parkinsons Disease Drug Product and Services
Table 10. Novartis AG Parkinsons Disease Drug Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. GSK Basic Information, Manufacturing Base and Competitors
Table 12. GSK Major Business
Table 13. GSK Parkinsons Disease Drug Product and Services
Table 14. GSK Parkinsons Disease Drug Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. AbbVie Basic Information, Manufacturing Base and Competitors
Table 16. AbbVie Major Business
Table 17. AbbVie Parkinsons Disease Drug Product and Services
Table 18. AbbVie Parkinsons Disease Drug Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Merck Basic Information, Manufacturing Base and Competitors
Table 20. Merck Major Business
Table 21. Merck Parkinsons Disease Drug Product and Services
Table 22. Merck Parkinsons Disease Drug Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 24. Boehringer Ingelheim Major Business
Table 25. Boehringer Ingelheim Parkinsons Disease Drug Product and Services
Table 26. Boehringer Ingelheim Parkinsons Disease Drug Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Impax Laboratories Basic Information, Manufacturing Base and Competitors
Table 28. Impax Laboratories Major Business
Table 29. Impax Laboratories Parkinsons Disease Drug Product and Services
Table 30. Impax Laboratories Parkinsons Disease Drug Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Lundbeck Basic Information, Manufacturing Base and Competitors
Table 32. Lundbeck Major Business
Table 33. Lundbeck Parkinsons Disease Drug Product and Services
Table 34. Lundbeck Parkinsons Disease Drug Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Sun Pharma Basic Information, Manufacturing Base and Competitors
Table 36. Sun Pharma Major Business
Table 37. Sun Pharma Parkinsons Disease Drug Product and Services
Table 38. Sun Pharma Parkinsons Disease Drug Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Wockhardt Basic Information, Manufacturing Base and Competitors
Table 40. Wockhardt Major Business
Table 41. Wockhardt Parkinsons Disease Drug Product and Services
Table 42. Wockhardt Parkinsons Disease Drug Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. UCB Basic Information, Manufacturing Base and Competitors
Table 44. UCB Major Business
Table 45. UCB Parkinsons Disease Drug Product and Services
Table 46. UCB Parkinsons Disease Drug Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Bausch Health Basic Information, Manufacturing Base and Competitors
Table 48. Bausch Health Major Business
Table 49. Bausch Health Parkinsons Disease Drug Product and Services
Table 50. Bausch Health Parkinsons Disease Drug Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Acadia Basic Information, Manufacturing Base and Competitors
Table 52. Acadia Major Business
Table 53. Acadia Parkinsons Disease Drug Product and Services
Table 54. Acadia Parkinsons Disease Drug Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Global Parkinsons Disease Drug Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Doses)
Table 56. Global Parkinsons Disease Drug Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 57. Market Position of Manufacturers in Parkinsons Disease Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 58. Global Parkinsons Disease Drug Production Capacity by Company, (K Doses): 2020 VS 2021
Table 59. Head Office and Parkinsons Disease Drug Production Site of Key Manufacturer
Table 60. Parkinsons Disease Drug New Entrant and Capacity Expansion Plans
Table 61. Parkinsons Disease Drug Mergers & Acquisitions in the Past Five Years
Table 62. Global Parkinsons Disease Drug Sales by Region (2017-2022) & (K Doses)
Table 63. Global Parkinsons Disease Drug Sales by Region (2023-2028) & (K Doses)
Table 64. Global Parkinsons Disease Drug Revenue by Region (2017-2022) & (USD Million)
Table 65. Global Parkinsons Disease Drug Revenue by Region (2023-2028) & (USD Million)
Table 66. Global Parkinsons Disease Drug Sales by Type (2017-2022) & (K Doses)
Table 67. Global Parkinsons Disease Drug Sales by Type (2023-2028) & (K Doses)
Table 68. Global Parkinsons Disease Drug Revenue by Type (2017-2022) & (USD Million)
Table 69. Global Parkinsons Disease Drug Revenue by Type (2023-2028) & (USD Million)
Table 70. Global Parkinsons Disease Drug Price by Type (2017-2022) & (USD/Dose)
Table 71. Global Parkinsons Disease Drug Price by Type (2023-2028) & (USD/Dose)
Table 72. Global Parkinsons Disease Drug Sales by Application (2017-2022) & (K Doses)
Table 73. Global Parkinsons Disease Drug Sales by Application (2023-2028) & (K Doses)
Table 74. Global Parkinsons Disease Drug Revenue by Application (2017-2022) & (USD Million)
Table 75. Global Parkinsons Disease Drug Revenue by Application (2023-2028) & (USD Million)
Table 76. Global Parkinsons Disease Drug Price by Application (2017-2022) & (USD/Dose)
Table 77. Global Parkinsons Disease Drug Price by Application (2023-2028) & (USD/Dose)
Table 78. North America Parkinsons Disease Drug Sales by Country (2017-2022) & (K Doses)
Table 79. North America Parkinsons Disease Drug Sales by Country (2023-2028) & (K Doses)
Table 80. North America Parkinsons Disease Drug Revenue by Country (2017-2022) & (USD Million)
Table 81. North America Parkinsons Disease Drug Revenue by Country (2023-2028) & (USD Million)
Table 82. North America Parkinsons Disease Drug Sales by Type (2017-2022) & (K Doses)
Table 83. North America Parkinsons Disease Drug Sales by Type (2023-2028) & (K Doses)
Table 84. North America Parkinsons Disease Drug Sales by Application (2017-2022) & (K Doses)
Table 85. North America Parkinsons Disease Drug Sales by Application (2023-2028) & (K Doses)
Table 86. Europe Parkinsons Disease Drug Sales by Country (2017-2022) & (K Doses)
Table 87. Europe Parkinsons Disease Drug Sales by Country (2023-2028) & (K Doses)
Table 88. Europe Parkinsons Disease Drug Revenue by Country (2017-2022) & (USD Million)
Table 89. Europe Parkinsons Disease Drug Revenue by Country (2023-2028) & (USD Million)
Table 90. Europe Parkinsons Disease Drug Sales by Type (2017-2022) & (K Doses)
Table 91. Europe Parkinsons Disease Drug Sales by Type (2023-2028) & (K Doses)
Table 92. Europe Parkinsons Disease Drug Sales by Application (2017-2022) & (K Doses)
Table 93. Europe Parkinsons Disease Drug Sales by Application (2023-2028) & (K Doses)
Table 94. Asia-Pacific Parkinsons Disease Drug Sales by Region (2017-2022) & (K Doses)
Table 95. Asia-Pacific Parkinsons Disease Drug Sales by Region (2023-2028) & (K Doses)
Table 96. Asia-Pacific Parkinsons Disease Drug Revenue by Region (2017-2022) & (USD Million)
Table 97. Asia-Pacific Parkinsons Disease Drug Revenue by Region (2023-2028) & (USD Million)
Table 98. Asia-Pacific Parkinsons Disease Drug Sales by Type (2017-2022) & (K Doses)
Table 99. Asia-Pacific Parkinsons Disease Drug Sales by Type (2023-2028) & (K Doses)
Table 100. Asia-Pacific Parkinsons Disease Drug Sales by Application (2017-2022) & (K Doses)
Table 101. Asia-Pacific Parkinsons Disease Drug Sales by Application (2023-2028) & (K Doses)
Table 102. South America Parkinsons Disease Drug Sales by Country (2017-2022) & (K Doses)
Table 103. South America Parkinsons Disease Drug Sales by Country (2023-2028) & (K Doses)
Table 104. South America Parkinsons Disease Drug Revenue by Country (2017-2022) & (USD Million)
Table 105. South America Parkinsons Disease Drug Revenue by Country (2023-2028) & (USD Million)
Table 106. South America Parkinsons Disease Drug Sales by Type (2017-2022) & (K Doses)
Table 107. South America Parkinsons Disease Drug Sales by Type (2023-2028) & (K Doses)
Table 108. South America Parkinsons Disease Drug Sales by Application (2017-2022) & (K Doses)
Table 109. South America Parkinsons Disease Drug Sales by Application (2023-2028) & (K Doses)
Table 110. Middle East & Africa Parkinsons Disease Drug Sales by Region (2017-2022) & (K Doses)
Table 111. Middle East & Africa Parkinsons Disease Drug Sales by Region (2023-2028) & (K Doses)
Table 112. Middle East & Africa Parkinsons Disease Drug Revenue by Region (2017-2022) & (USD Million)
Table 113. Middle East & Africa Parkinsons Disease Drug Revenue by Region (2023-2028) & (USD Million)
Table 114. Middle East & Africa Parkinsons Disease Drug Sales by Type (2017-2022) & (K Doses)
Table 115. Middle East & Africa Parkinsons Disease Drug Sales by Type (2023-2028) & (K Doses)
Table 116. Middle East & Africa Parkinsons Disease Drug Sales by Application (2017-2022) & (K Doses)
Table 117. Middle East & Africa Parkinsons Disease Drug Sales by Application (2023-2028) & (K Doses)
Table 118. Parkinsons Disease Drug Raw Material
Table 119. Key Manufacturers of Parkinsons Disease Drug Raw Materials
Table 120. Direct Channel Pros & Cons
Table 121. Indirect Channel Pros & Cons
Table 122. Parkinsons Disease Drug Typical Distributors
Table 123. Parkinsons Disease Drug Typical Customers
List of Figures
Figure 1. Parkinsons Disease Drug Picture
Figure 2. Global Parkinsons Disease Drug Revenue Market Share by Type in 2021
Figure 3. Carbidopa/Levodopa
Figure 4. Dopamine Receptor Agonists
Figure 5. MAO-Inhibitors
Figure 6. Global Parkinsons Disease Drug Revenue Market Share by Application in 2021
Figure 7. Hospital
Figure 8. Clinics
Figure 9. Other
Figure 10. Global Parkinsons Disease Drug Revenue, (USD Million) & (K Doses): 2017 & 2021 & 2028
Figure 11. Global Parkinsons Disease Drug Revenue and Forecast (2017-2028) & (USD Million)
Figure 12. Global Parkinsons Disease Drug Sales (2017-2028) & (K Doses)
Figure 13. Global Parkinsons Disease Drug Price (2017-2028) & (USD/Dose)
Figure 14. Global Parkinsons Disease Drug Production Capacity (2017-2028) & (K Doses)
Figure 15. Global Parkinsons Disease Drug Production Capacity by Geographic Region: 2022 VS 2028
Figure 16. Parkinsons Disease Drug Market Drivers
Figure 17. Parkinsons Disease Drug Market Restraints
Figure 18. Parkinsons Disease Drug Market Trends
Figure 19. Global Parkinsons Disease Drug Sales Market Share by Manufacturer in 2021
Figure 20. Global Parkinsons Disease Drug Revenue Market Share by Manufacturer in 2021
Figure 21. Parkinsons Disease Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 22. Top 3 Parkinsons Disease Drug Manufacturer (Revenue) Market Share in 2021
Figure 23. Top 6 Parkinsons Disease Drug Manufacturer (Revenue) Market Share in 2021
Figure 24. Global Parkinsons Disease Drug Sales Market Share by Region (2017-2028)
Figure 25. Global Parkinsons Disease Drug Revenue Market Share by Region (2017-2028)
Figure 26. North America Parkinsons Disease Drug Revenue (2017-2028) & (USD Million)
Figure 27. Europe Parkinsons Disease Drug Revenue (2017-2028) & (USD Million)
Figure 28. Asia-Pacific Parkinsons Disease Drug Revenue (2017-2028) & (USD Million)
Figure 29. South America Parkinsons Disease Drug Revenue (2017-2028) & (USD Million)
Figure 30. Middle East & Africa Parkinsons Disease Drug Revenue (2017-2028) & (USD Million)
Figure 31. Global Parkinsons Disease Drug Sales Market Share by Type (2017-2028)
Figure 32. Global Parkinsons Disease Drug Revenue Market Share by Type (2017-2028)
Figure 33. Global Parkinsons Disease Drug Price by Type (2017-2028) & (USD/Dose)
Figure 34. Global Parkinsons Disease Drug Sales Market Share by Application (2017-2028)
Figure 35. Global Parkinsons Disease Drug Revenue Market Share by Application (2017-2028)
Figure 36. Global Parkinsons Disease Drug Price by Application (2017-2028) & (USD/Dose)
Figure 37. North America Parkinsons Disease Drug Sales Market Share by Type (2017-2028)
Figure 38. North America Parkinsons Disease Drug Sales Market Share by Application (2017-2028)
Figure 39. North America Parkinsons Disease Drug Sales Market Share by Country (2017-2028)
Figure 40. North America Parkinsons Disease Drug Revenue Market Share by Country (2017-2028)
Figure 41. United States Parkinsons Disease Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Canada Parkinsons Disease Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Mexico Parkinsons Disease Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Europe Parkinsons Disease Drug Sales Market Share by Type (2017-2028)
Figure 45. Europe Parkinsons Disease Drug Sales Market Share by Application (2017-2028)
Figure 46. Europe Parkinsons Disease Drug Sales Market Share by Country (2017-2028)
Figure 47. Europe Parkinsons Disease Drug Revenue Market Share by Country (2017-2028)
Figure 48. Germany Parkinsons Disease Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. France Parkinsons Disease Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. United Kingdom Parkinsons Disease Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Russia Parkinsons Disease Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Italy Parkinsons Disease Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Asia-Pacific Parkinsons Disease Drug Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Parkinsons Disease Drug Sales Market Share by Application (2017-2028)
Figure 55. Asia-Pacific Parkinsons Disease Drug Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Parkinsons Disease Drug Revenue Market Share by Region (2017-2028)
Figure 57. China Parkinsons Disease Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Japan Parkinsons Disease Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Korea Parkinsons Disease Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. India Parkinsons Disease Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Southeast Asia Parkinsons Disease Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Australia Parkinsons Disease Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. South America Parkinsons Disease Drug Sales Market Share by Type (2017-2028)
Figure 64. South America Parkinsons Disease Drug Sales Market Share by Application (2017-2028)
Figure 65. South America Parkinsons Disease Drug Sales Market Share by Country (2017-2028)
Figure 66. South America Parkinsons Disease Drug Revenue Market Share by Country (2017-2028)
Figure 67. Brazil Parkinsons Disease Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Argentina Parkinsons Disease Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Middle East & Africa Parkinsons Disease Drug Sales Market Share by Type (2017-2028)
Figure 70. Middle East & Africa Parkinsons Disease Drug Sales Market Share by Application (2017-2028)
Figure 71. Middle East & Africa Parkinsons Disease Drug Sales Market Share by Region (2017-2028)
Figure 72. Middle East & Africa Parkinsons Disease Drug Revenue Market Share by Region (2017-2028)
Figure 73. Turkey Parkinsons Disease Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Egypt Parkinsons Disease Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Saudi Arabia Parkinsons Disease Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. South Africa Parkinsons Disease Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Manufacturing Cost Structure Analysis of Parkinsons Disease Drug in 2021
Figure 78. Manufacturing Process Analysis of Parkinsons Disease Drug
Figure 79. Parkinsons Disease Drug Industrial Chain
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Parkinson's Disease Therapeutics Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 99

Parkinson's disease (PD), or simply Parkinson's, is a chronic degenerative disorder of The central nervous system that affects both The motor system and non-motor systems. The symptoms usually emerge slowly, and as The disease worsens, non-motor symptoms become more common. Early symptoms are tremor, rigidity, slowness of movement, and difficulty with walking. Problems may also arise with cognition, behaviour, sleep, and sensory systems. Parkinson's disease dementia becomes common in advanced st......

Global Amantadine Hydrochloride Market Insights, Forecast to 2029

Published: 29-Aug-2023        Price: US 4900 Onwards        Pages: 109

Amantadine hydrochloride (CAS 665-66-7), C10H18ClN, the formula weight is 187.71, and its form is white crystal powder. The global Amantadine Hydrochloride market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period. Amantadine hydrochloride is clinically effective in preventing and treating infections of various influenza A viruses. In the influenza epidemic period, this product is use......

Global Rasagiline Tablet Market Insights, Forecast to 2029

Published: 11-Aug-2023        Price: US 4900 Onwards        Pages: 107

Rasagiline (Azilect, Azipron) is an irreversible inhibitor of monoamine oxidase-B used as a monotherapy to treat symptoms in early Parkinson's disease or as an adjunct therapy in more advanced cases. The global Rasagiline Tablet market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period. The racemic form of the drug was invented by Aspro Nicholas in the early 1970s. Moussa B.H. Youdim identifi......

Global Parkinsons Disease Drug Market Insights, Forecast to 2029

Published: 02-Aug-2023        Price: US 4900 Onwards        Pages: 113

Most people with Parkinson's disease eventually need a medication called levodopa. Levodopa is absorbed by the nerve cells in your brain and turned into the chemical dopamine, which is used to transmit messages between the parts of the brain and nerves that control movement. The global Parkinsons Disease Drug market is projected to grow from US$ 5763.6 million in 2023 to US$ 7419.9 million by 2029, at a Compound Annual Growth Rate (CAGR) of 4.3% during the forecast period. Global P......

Global Rasagiline Tablet Market Research Report 2023, Forecast to 2028

Published: 20-Mar-2023        Price: US 2680 Onwards        Pages: 137

Rasagiline is used alone or with other medications (such as levodopa/carbidopa) to treat symptoms of Parkinson's disease. It can help improve symptoms such as shakiness, stiffness, and difficulty moving. It can also help reduce the amount of "off" time (periods of slow movement or stiffness). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data fo......

Global Rasagiline Tablet Professional Survey Report 2023, Forecast to 2028

Published: 20-Mar-2023        Price: US 3280 Onwards        Pages: 109

Rasagiline is used alone or with other medications (such as levodopa/carbidopa) to treat symptoms of Parkinson's disease. It can help improve symptoms such as shakiness, stiffness, and difficulty moving. It can also help reduce the amount of "off" time (periods of slow movement or stiffness). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data fo......

Global Amantadine Hydrochloride Market Research Report 2023

Published: 09-Mar-2023        Price: US 2900 Onwards        Pages: 98

Amantadine hydrochloride (CAS 665-66-7), C10H18ClN, the formula weight is 187.71, and its form is white crystal powder. Highlights The global Amantadine Hydrochloride market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. Amantadine hydrochloride is clinically effective......

Global Parkinson's Disease (PD) Drugs Professional Survey Report 2023, Forecast to 2028

Published: 21-Feb-2023        Price: US 3280 Onwards        Pages: 133

Levodopa, the most effective Parkinson's disease medication, is a natural chemical that passes into your brain and is converted to dopamine. Levodopa is combined with carbidopa (Lodosyn), which protects levodopa from early conversion to dopamine outside your brain. This prevents or lessens side effects such as nausea. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market v......

Global Parkinson's Disease (PD) Drugs Market Research Report 2023, Forecast to 2028

Published: 21-Feb-2023        Price: US 2680 Onwards        Pages: 159

Levodopa, the most effective Parkinson's disease medication, is a natural chemical that passes into your brain and is converted to dopamine. Levodopa is combined with carbidopa (Lodosyn), which protects levodopa from early conversion to dopamine outside your brain. This prevents or lessens side effects such as nausea. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market v......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs